- CSL to lay off up to 15% of workforce, cut R&D costs and spin out vaccine unit Fierce Biotech
- CSL to Spin Off Seqirus, Cut Up to 15% of Staff in Sweeping Restructure – WSJ The Wall Street Journal
- CSL Shares Slump as Disappointing Profit Eclipses Spinoff Bloomberg.com
- CSL shares dive as biotech firm flags more than 3,000 job cuts — as it happened Australian Broadcasting Corporation
- CSL to axe up to 3,000 employees and spin off vaccine arm; shares tumble Reuters
Source link
